跳至主要内容
临床试验/KCT0001737
KCT0001737已完成未知

A 12 week, randomized, double-blind and placebo-controlled clinical trial to assess the efficacy and safety of soy isoflavone in postmenopausal women

Dr.Chung's Food0 个研究点目标入组 96 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
45(Year) 至 60(Year)(—)
性别
Female

入选标准

  • ?last spontaneous menstrual bleeding>12 month ago, aged 45-60 years
  • ?hot flushes continued for at least three month
  • ?Kupperman index ranged 20 to 40
  • ?Serum follicle-stimulating hormone (FSH) levels >= 40 IU /ml.
  • ?BMI ranging between 19.0 to 30 kg/m2
  • ?Written informed consent

排除标准

  • ? women who have hysterectomy or chemotherapy
  • ? women who have abnormal finding such as endometrial proliferation, endometrial cancer and uterine cervical cancer related condition
  • ? women who have breast cancer related condition
  • ? women who received hormone replacement therapy or selective estrogen receptor modulators (SERMS) within five years of enrollment
  • ? women who vaginal bleeding, unknown cause within six month of enrollment
  • ? Women who have heart, kidney and thyroid disease
  • ? Women who have depression and schizophrenia
  • ? women who received hormone replacement therapy or selective estrogen receptor modulators (SERMS) within three month of enrollment
  • ? Patient with systolic blood pressure =170 mmHg and diastolic pressure =100 mmHg, or hypertensive person who take diuretics (170/100 mmHg, at the screening)
  • ? who had uncontrolled bood glucose (IFG 180 mg/dl mmHg, at the screening)
  • ? who had soy allergy
  • ? who participated other clinical trial within 3 months prior to this study
  • ? who are not considrered to be appropriate to particiapt on this study

研究者

发起方
Dr.Chung's Food

相似试验

Clinical trial for efficacy of soy isoflavone in... | 临床试验